Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: A review

被引:48
|
作者
Luscombe, FA
机构
[1] Richland, MI 49083
关键词
colonic diseases; functional; quality of life; questionnaires;
D O I
10.1023/A:1008970312068
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Irritable Bowel Syndrome (IBS) is a chronic recurring disorder with variable illness episodes that may continue for many years. Diagnosis is based on symptoms such as abdominal pain and irregular bowel habits. These symptoms, plus the influence of psychological factors and extraintestinal symptoms, adversely affect the health-related quality of life (HRQoL) of individuals with IBS. This paper summarizes publications relating to the characteristics of IBS and associated HRQoL. Significantly lower scores on both the physical and mental health scales of the Short Form-36 are reported for individuals with IBS symptoms as compared with asymptomatic controls and US norms. IBS negatively affects general health, vitality, social functioning, bodily pain, diet, sexual function, sleep, and is associated with lost time from work. IBS-specific instruments that incorporate many of these domains have recently become available. HRQoL appears to correlate with IBS symptom severity and influences decisions to seek medical care. Psychosocial problems are also linked with IBS in relation to health care utilization. However, the full burden of this painful illness is still unknown since only 25-60% of individuals suffering from IBS symptoms see a physician for their illness.
引用
下载
收藏
页码:161 / 176
页数:16
相关论文
共 50 条
  • [1] Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: A review
    Faye A. Luscombe
    Quality of Life Research, 2000, 9 : 161 - 176
  • [2] SOMATIC AND PSYCHOSOCIAL FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN CHILDREN WITH IRRITABLE BOWEL SYNDROME AND HEALTHY CONTROLS
    Hollier, John M.
    Czyzewski, Danita I.
    Self, Mariella M.
    Liu, Yan
    Weidler, Erica M.
    van Tilburg, Miranda A.
    Varni, James W.
    Shulman, Robert J.
    GASTROENTEROLOGY, 2019, 156 (06) : S1060 - S1060
  • [3] The impact of irritable bowel syndrome on health-related quality of life
    Gralnek, IM
    Hays, RD
    Kilbourne, A
    Naliboff, B
    Mayer, EA
    GASTROENTEROLOGY, 2000, 119 (03) : 654 - 660
  • [4] Health-Related Quality of Life Associated with Chronic Constipation or Irritable Bowel Syndrome with Constipation
    Xu, Yaping
    Lasch, Karen
    Wagner, Samuel
    Chapnick, Jonathan
    Dabbous, Omar
    GASTROENTEROLOGY, 2009, 136 (05) : A485 - A485
  • [5] Health-related quality of life among persons with irritable bowel syndrome: a systematic review
    El-Serag, HB
    Olden, K
    Bjorkman, D
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) : 1171 - 1185
  • [6] Impact of irritable bowel syndrome on health-related quality of life (HRQOL).
    Mayer, EA
    Hays, RD
    Kilbourne, A
    Mayer, EA
    Yei, JY
    GASTROENTEROLOGY, 1999, 116 (04) : A1038 - A1038
  • [7] Clinical determinants of health-related quality of life in irritable bowel syndrome
    Spiegel, BMR
    Gralnek, IM
    Mayer, EA
    Bolus, R
    Chang, L
    Dulai, GS
    Naliboff, B
    GASTROENTEROLOGY, 2003, 124 (04) : A398 - A398
  • [8] Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?
    Spiegel, BMR
    Gralnek, IM
    Bolus, R
    Chang, L
    Dulai, GS
    Naliboff, B
    Mayer, EA
    GASTROINTESTINAL ENDOSCOPY, 2005, 62 (06) : 892 - 899
  • [9] Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?
    Spiegel, BMR
    Gralnek, IM
    Mayer, EA
    Bolus, R
    Lin, C
    Dulai, GS
    Naliboff, B
    GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB112 - AB112
  • [10] Health-related quality of life associated with irritable bowel syndrome: Comparison with other chronic diseases
    Frank, L
    Kleinman, L
    Rentz, A
    Ciesla, G
    Kim, JJ
    Zacker, C
    CLINICAL THERAPEUTICS, 2002, 24 (04) : 675 - 689